美股市場個股詳情
EMBC Embecta
- 20.830
- +0.240+1.17%
收盤價 11/29 13:00 (美東)
- 20.600
- -0.230-1.10%
盤後 17:01 (美東)
12.02億總市值15.54市盈率TTM
20.860最高價19.750最低價36.63萬股成交量20.160今開20.590昨收750.09萬成交額0.68%換手率15.54市盈率(靜)5770.73萬總股本20.86052周最高-1.63市淨率11.21億流通值9.70752周最低0.60股息TTM5382.08萬流通股45.691歷史最高2.88%股息率TTM5.39%振幅9.707歷史最低20.478平均價1股每手
關於Embecta公司
Embecta Corp 是一家醫療技術公司。 該公司開發創新技術、服務和解決方案，幫助推進患者的臨牀治療和醫療保健提供者的臨牀流程。 其產品包括 BD Pyxis、PureWick、Phasix 等。
公司介紹
公司代碼EMBC
公司名稱Embecta
上市日期2022/03/22
成立日期1924
CEOMr. Devdatt Kurdikar
所屬市場納斯達克
員工數量2200
年結日09-30
公司地址300 Kimball Drive,Suite 300
城市Parsippany
省份新澤西
國家美國
郵編07417-07054
電話1-862-401-0000
董事高管
-
姓名
- 職務
- 年薪
-
Devdatt Kurdikar
- Director, President and Chief Executive Officer
- 746.45萬
-
Jacob Elguicze
- Interim Principal Accounting Officer, Senior Vice President and Chief Financial Officer
- 258.34萬
-
Colleen Riley
- Senior Vice President and Chief Technology Officer
- --
-
Jean M. Casner
- Senior Vice President and Chief Human Resources Officer
- --
-
Ginny Blocki
- Senior Vice President, Product Management and Global Marketing
- --
-
Shaun Curtis
- Senior Vice President, Global Manufacturing and Supply Chain
- 149.04萬
-
Tom Blount
- Senior Vice President and President, North America
- --
-
Jeffrey Z. Mann
- Senior Vice President, General Counsel, Head of Corporate Development and Corporate Secretary
- 220.48萬
-
Slobodan Radumilo
- Senior Vice President and President, International
- --
-
General David F. Melcher
- Non-Executive Chairman of the Board
- 46.00萬
-
Robert J. Hombach
- Independent Director
- 28.80萬
-
Christopher R. Reidy
- Independent Director
- 28.80萬
-
Dr. Claire Pomeroy, M.B.A.,M.D.
- Independent Director
- 29.30萬
-
David J. Albritton
- Independent Director
- 27.23萬
-
Dr. Milton M. Morris,PhD
- Independent Director
- 27.70萬
-
Carrie L. Anderson
- Independent Director
- 27.20萬
-
Karen N. Prange
- Independent Director
- 28.80萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據